Wockhardt files fast – acting Insulin Aspart injection (ASPARAPID™) with DCGI; strengthens commitment to diabetes management
Wockhardt files fast – acting Insulin Aspart injection (ASPARAPID™) with DCGI; strengthens commitment to diabetes management
Wockhardt’s yet another novel antibiotic Miqnaf™ (Nafithromycin) receives favourable recommendation from Subject Expert Committee of Central Drugs Standard Control Organization (CDSCO) for the Treatment for Community – Acquired Bacterial Pneumonia (CABP)
